Searched for
EASYSIX VACCINE
Dispute with Sanofi settled, Panacea scrip soars to over 3-yr highPanacea Biotec has settled a patent dispute with Sanofi Healthcare India, leading to a rise in its stock. The Delhi High Court case involve...- Panacea, Sanofi settle patent litigation over hexavalent vaccinePanacea Biotec has settled a patent infringement case with Sanofi Healthcare India over a hexavalent vaccine. Sanofi will not launch its Sh...
- Panacea Biotec gets $20 million loan from US government for hexavalent vaccine capacity expansionPanacea Biotec has secured a $20 million long-term loan from the US International Development Finance Corporation to expand its hexavalent ...
- DFC commits USD 20 mn long-term loan to Panacea BiotecUS International Development Finance Corporation has committed a long-term loan of up to USD 20 million to Panacea Biotec. The funds will h...
- Panacea Biotec files suit against Sanofi for patent infringement"The suit filed against Sanofi comes at the heels of Sanofi having received marketing approval for a Whole Cell Pertussis based Hexavalent ...
- Are companies bribing doctors to push vaccine combos?Paediatricians question these huge price increases with the addition of just one more vaccine.
- Panacea Biotec says newly developed vaccine works better than its peersEasySixTM is a fully liquid ready-to-use hexavalent vaccine made using high quality antigens complying to WHO’s cGMP requirements."
Load More